Breviscapine alleviates liver fibrosis by inhibiting epithelial-mesenchymal transition via TGF-beta1/Smad3 pathway.

Zhong XH, Li Y, Song YK, Sun YM, Zhang DF, Ge HC, He YL

Open source

DOI
10.1080/10286020.2026.2697867
Published
2026 Jul 14
Container
Journal of Asian natural products research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/10286020.2026.2697867,
  title = {Breviscapine alleviates liver fibrosis by inhibiting epithelial-mesenchymal transition via TGF-beta1/Smad3 pathway.},
  author = {Zhong XH and Li Y and Song YK and Sun YM and Zhang DF and Ge HC and He YL},
  year = {2026},
  journal = {Journal of Asian natural products research},
  doi = {10.1080/10286020.2026.2697867},
  url = {https://doi.org/10.1080/10286020.2026.2697867}
}

RIS

TY  - JOUR
TI  - Breviscapine alleviates liver fibrosis by inhibiting epithelial-mesenchymal transition via TGF-beta1/Smad3 pathway.
AU  - Zhong XH
AU  - Li Y
AU  - Song YK
AU  - Sun YM
AU  - Zhang DF
AU  - Ge HC
AU  - He YL
PY  - 2026
JO  - Journal of Asian natural products research
DO  - 10.1080/10286020.2026.2697867
UR  - https://doi.org/10.1080/10286020.2026.2697867
ER  - 

APA

XH, Z., Y, L., YK, S., YM, S., DF, Z., HC, G., & YL, H. (2026). Breviscapine alleviates liver fibrosis by inhibiting epithelial-mesenchymal transition via TGF-beta1/Smad3 pathway.. Journal of Asian natural products research. https://doi.org/10.1080/10286020.2026.2697867

Source records